CMRX - CHIMERIX INC

QQQ $ 451.64 $ -1.83 (-0.4 %)

DIA $ 399.14 $ -0.14 (-0.04 %)

SPY $ 528.49 $ -1.29 (-0.24 %)

TLT $ 92.06 $ -0.04 (-0.04 %)

GLD $ 220.06 $ -0.83 (-0.38 %)

Previous Close

$ 0.9775

Open

$ 0.97

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 0.96 - $ 0.97

52 Week Range

$ 0.88 - $ 1.57

Volume

121,146

Average Volume

Market Cap

87.25M

Beta (5Y Monthly)

$ 1.31

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-01-2024	03-31-2024	10-Q
2	02-29-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-03-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	03-02-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-08-2022	06-30-2022	10-Q
9	05-16-2022	03-31-2022	10-Q
10	03-01-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	02-25-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-10-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	02-25-2020	12-31-2019	10-K
19	11-05-2019	09-30-2019	10-Q
20	08-08-2019	06-30-2019	10-Q
21	05-09-2019	03-31-2019	10-Q
22	03-05-2019	12-31-2018	10-K
23	11-08-2018	09-30-2018	10-Q
24	08-08-2018	06-30-2018	10-Q
25	05-07-2018	03-31-2018	10-Q
26	03-01-2018	12-31-2017	10-K
27	11-08-2017	09-30-2017	10-Q
28	08-07-2017	06-30-2017	10-Q
29	05-09-2017	03-31-2017	10-Q
30	03-02-2017	12-31-2016	10-K
31	11-07-2016	09-30-2016	10-Q
32	08-08-2016	06-30-2016	10-Q
33	05-09-2016	03-31-2016	10-Q
34	02-29-2016	12-31-2015	10-K
35	11-05-2015	09-30-2015	10-Q
36	08-06-2015	06-30-2015	10-Q
37	05-11-2015	03-31-2015	10-Q
38	03-06-2015	12-31-2014	10-K
39	11-07-2014	09-30-2014	10-Q
40	08-07-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Chimerix Expects Dordaviprone Interim Over...
05/01/2024 11:13:10

Dordaviprone is an oral, first-in-class small molecule imipridone that selectively binds to the G-protein coupled dopamine rece...

Chimerix Q1 2024 GAAP EPS $(0.25) Misses $...
05/01/2024 11:06:25

Chimerix (NASDAQ:CMRX) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.21) by...

WHO's Tedros Adhanom Ghebreyesus Posts On ...
04/11/2024 14:09:23

https://twitter.com/DrTedros/status/1778423967105139108

HC Wainwright & Co. Reiterates Buy on Chim...
03/01/2024 12:14:30

HC Wainwright & Co. analyst Edward White reiterates Chimerix (NASDAQ:CMRX) with a Buy and maintains $11 price target.

Chimerix Q4 Cash and Equivalents $204M
02/29/2024 12:06:07

Chimerix Q4 EPS $(0.20) Beats $(0.24) Esti...
02/29/2024 12:05:32

Chimerix (NASDAQ:CMRX) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.24) by 1...

Earnings Scheduled For February 29, 2024
02/29/2024 10:15:24

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

Preview: Chimerix's Earnings
02/28/2024 19:01:18

Reported Earlier, "WHO 'Very Worried' Abou...
12/08/2023 17:31:10

https://www.reuters.com/business/healthcare-pharmaceuticals/who-very-worried-about-spread-mpox-drc-2023-12-08/?taid=65734f21df0...

Chimerix Announced The Promotion Of Michel...
12/04/2023 12:17:53

Chimerix Expects To End 2023 With Over $20...
11/02/2023 11:02:59

Chimerix Q3 EPS $(0.27) Misses $(0.23) Est...
11/02/2023 11:01:32

Chimerix (NASDAQ: CMRX) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.23) b...

Earnings Scheduled For November 2, 2023
11/02/2023 08:56:34

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on...

Earnings Outlook For Chimerix
11/01/2023 19:01:39

NetSol Technologies And 2 Other Stocks Und...
09/27/2023 13:14:46

The Dow Jones closed lower by around 388 points on Tuesday. When insiders purchase or sell shares, it indicates their confidenc...

overview-of-value-stocks-in-the-healthcare-sector

Overview Of Value Stocks In The Healthcare...
09/18/2023 14:43:44

'CHP Investigates Two Confirmed Mpox Cases...
08/18/2023 13:00:09

https://www.info.gov.hk/gia/general/202308/18/P2023081800615.htm

4 Analysts Have This to Say About Chimerix
08/17/2023 20:00:18

Wedbush Reiterates Outperform on Chimerix,...
08/17/2023 12:29:38

Wedbush analyst David Nierengarten reiterates Chimerix (NASDAQ:CMRX) with a Outperform and maintains $6 price target.

HC Wainwright & Co. Reiterates Buy on Chim...
08/16/2023 16:51:31

HC Wainwright & Co. analyst Edward White reiterates Chimerix (NASDAQ:CMRX) with a Buy and maintains $11 price target.